Michael D. Cannon's most recent trade in Moleculin Biotech Inc was a trade of 10,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Nov. 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | Michael D. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 10,000 | 15,336 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Michael D. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 15,000 | 80,001 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Michael D. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 23,333 | 50,001 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Michael D. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 15,000 | 65,001 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Michael D. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 10,000 | 26,668 | - | - | Stock option (right to buy) |